Lv1
20 积分 2022-02-17 加入
Recent advances in the discovery of PKMYT1-targeting drugs: a patent review (2021–2025)
1个月前
已完结
The importance of plasma protein and tissue binding in a drug discovery program to successfully deliver a preclinical candidate
1个月前
已完结
Discovery of Tetracyclic Derivatives as Highly Potent, Selective, and Bioavailable PKMYT1 Inhibitors for Cancer Therapy
1个月前
已完结
Re-Evaluating Antibody–Drug Conjugate Linker Stability: Assessment, Interpretation, and Clinical Translation
1个月前
已完结
Systematic Evaluation of Maleimide Spacer Impact on Drug-Linker Deconjugation in Antibody-Drug Conjugates Ex Vivo and In Vivo
2个月前
已完结
Excretion of Drugs and Their Metabolites into the Bile
3个月前
已完结
Perspectives on the use of machine learning for ADME prediction at AstraZeneca
3个月前
已完结
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
4个月前
已完结
Prediction of Human Drug Clearance from Two Species: A Comparison of Several Allometric Methods
4个月前
已完结
Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial
4个月前
已关闭
皖公网安备34019202002308
